Delivery Order SPE2DB22D2206-SPE2DB24FEG56
Award Date
11/21/23
Potential Completion Date
11/22/23
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,891.25 delivery order contract is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,988.25 firm fixed-price contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on January 28, 2025. The award is part of a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,456.39 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,705.82 firm-fixed-price delivery order is for the provision of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award has a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $56,834.34, is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $6,374.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REXULTI 0.25 MG TABLET 30S, a pharmaceutical product, with a completion date of November 7, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,759.61 Firm Fixed Price Delivery Order contract is for the supply of REXULTI 1 MG TABLET 30S, a medication used in the treatment of certain mental health conditions. The contract has an ultimate completion date of December 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $9,174.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The award has an Ultimate Completion Date of February 12, 2025 and a Firm Fixed Price pricing type. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $2,655.96 and an ultimate completion date of June 3, 2024. The contract is for the supply of the pharmaceutical product REXULTI 1 MG TABLET 30S. This award does not have a set-aside designation, indicating open...
This federal contract award, valued at $16,854.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 24, 2025. The contract covers the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to support DLA's medical supply requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...